OraSure Technologies (OSUR) Misses Q2 EPS by 2c, provides guidance
Tweet
Share
E-mail
Get Alerts OSUR Hot Sheet
Price: $3.71 -1.85%
Financial Fact:
Research and development: 3.2M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Research and development: 3.2M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
OraSure Technologies (NASDAQ: OSUR) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $31.24 million versus the consensus estimate of $30.52 million.
GUIDANCE:
OraSure Technologies sees Q3 2025 revenue of $27-30 million, versus the consensus of $33.97 million.
For earnings history and earnings-related data on OraSure Technologies (OSUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- CuriosityStream names Sean Piche as CFO, effective September 1
- Arcline completes all-cash acquisition of AstroNova at $29 per share
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
